Worcester Medicaid payments for COVID-related care reached $460,632 in 2024

In 2024, Medicaid claims for services billed under HCPCS codes specifically tied to COVID-19 amounted to at least $460,632 in Worcester, based on figures from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, administered through partnerships between state and federal governments, funds health insurance for low-income individuals, families, seniors, children, and people with disabilities. This makes Medicaid one of the largest segments within the nation’s health care landscape. More on its funding can be found here.

Since Medicaid payments come from public sources, shifts in claim volumes offer insight into how public health care resources are distributed in local communities.

This report identifies COVID-19–related services by using HCPCS codes listed or categorized as “COVID-19” or “coronavirus” within billing details or associated reference standards. These figures include only services officially labeled as COVID-related in billing data, not broader pandemic-related care filed under generic codes.

For context, Boston topped Massachusetts locations for Medicaid outlays related to COVID-19 services in 2024, totaling $691,711 in virus-specific claims.

Worcester had 13 providers filing Medicaid claims for COVID-19–linked services in 2024. The majority of charges came from the COVID Specific codes, which totaled $346,039, alongside $88,539 billed for COVID-19 Vaccine Administration.

On average, per-provider Medicaid payments for COVID-related services in Worcester stood at $35,433, compared to a statewide average of $28,676.

COVID-specific claims made up a significant share of increases in Medicaid spending in Worcester during the pandemic response period.

Total Medicaid disbursements for all other claims climbed $34,606,884 from 2020 through 2024—an 8.9% uptick over that span.

According to the Centers for Medicare & Medicaid Services, federally and state-funded Medicaid spending was about $871.7 billion during fiscal 2023, which represented roughly 18% of total U.S. health outlays. This was up sharply from $613.5 billion in 2019, prior to the pandemic onset.

This overall increase reflects roughly 40% growth, primarily due to expanded enrollment and the higher demand seen during and after the pandemic period.

Recent national legislation, passed under the Trump administration, proposed major changes including federal funding cuts to Medicaid and increased requirements for enrollees. The “One Big Beautiful Bill Act,” enacted in 2025, is projected to trim more than $1 trillion from federal Medicaid allocations across the next decade and to set policies such as work requirements and greater cost-sharing. These would increase fiscal pressure on states and may curb federal growth in the program, while Medicaid continues supporting tens of millions of individuals.

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

This article uses information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original data set is available here.